China’s first reusable rocket Zhuque-3 fails recovery, leaving US in the lead

Beijing-based commercial space company LandSpace launched China’s first reusable rocket, Zhuque-3, from Jiuquan Satellite Launch Centre and reached low-Earth orbit, but the first stage caught fire during descent and crashed near the planned recovery pad, resulting in a failed recovery test. LandSpace says the anomaly occurred in the landing phase and is under investigation; the setback slows China’s bid to join the U.S. as a country capable of returning orbital-class boosters and may weigh on investor sentiment toward Chinese private space operators.

Analysis

Market structure: The failed Zhuque‑3 recovery is a net positive for established US aerospace primes (RTX, LMT, BA) and listed commercial launchers (RKLB, MAXR) because it slows credible near‑term competition for orbital-class, reusable boosters; expect a 3–12 month window of pricing power retention for incumbents and small-sat launchers. Direct losers are private Chinese launch entrants (LandSpace et al.) and suppliers to them—near‑term fundraising/valuation pressure is likely for private Chinese space startups and specialty component vendors.

Risk assessment: Tail risks include an accelerated Chinese state bailout that rapidly subsidizes re‑flights (high impact, low prob.) or a cross‑border regulatory clampdown on US sales to Chinese aerospace (medium prob.). Immediate market reaction will be sentiment‑driven (days–weeks); technical/orderbook impacts materialize over months and strategic market share shifts over multiple quarters to years. Hidden dependency: insurance and reinsurer pricing for launches could reprice materially if failure rates rise, compressing dealer margins for startups.

Trade implications: Prefer defensive A&D exposure and select commercial-launch longs: establish modest long positions in RKLB (small launcher optionality) and RTX/LMT as cash‑flowing defense hedges; use FXI puts to hedge China‑specific tail. Options: use calendar or 3‑6 month call spreads on RKLB to capture asymmetric upside with defined risk while buying 3‑month 5% OTM puts on FXI to protect against policy‑driven China selloffs.

Contrarian angles: Consensus treats this as terminal failure for Chinese reusability—history (SpaceX early failures) shows serial failures often precede rapid progress, so underweighting China long‑term exposure may be premature. The market may be overpricing short‑term protection; if China posts two successful returns within 6–12 months, short A&D overwrites and long Chinese capex plays will suffer significant mean reversion.

Key Decisions for Investors

• Establish a 2% portfolio long in Rocket Lab (RKLB) within 2 weeks: target +30% in 6–12 months, place a hard stop at -15% to capture near‑term re‑routing of small‑sat launch demand.
• Add a 1.5% defensive long in RTX (RTX) or LMT (split 1% RTX / 0.5% LMT) as a 6–12 month hedge against higher spending on assured launch capability; target +10–15%, stop -8%.
• Buy 3‑month call spreads on RKLB (ATM to +15% strikes) sized at 0.5–1% notional to exploit post‑failure volatility; max loss = premium, roll if implied vol >40% and time decay compresses.
• Purchase 3‑month 5% OTM puts on FXI (China equity proxy) sized 1% notional to hedge policy/regulatory shock to Chinese commercial space; unwind if CNY firming >1% vs USD or two consecutive successful Chinese booster recoveries within 6 months.
• Rebalance exposures after next two Chinese reusable attempts (monitor launches over next 3–6 months); if China records ≥2 successful soft landings, reduce A&D longs by 50% and rotate 75% of proceeds into select China industrials/satellite OEMs.